Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Acetylsalicylic Acid for Pre-eclampsia Prevention in Frozen Embryo Transfer
NCT05460416Phase 3Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Liège
- Start
- Oct 2022
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin in preeclampsia (2 arms), sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoint: Mean number of women suffering from pre-eclampsia. Started Oct 2022; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT05460416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05460416.